Philipps-Universität Marburg

University / College


Location: Marburg, Germany (DE) DE

ISNI: 0000000419369756

ROR: https://ror.org/01rdrb571

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy (2022) Leichsenring J, Vladimirova V, Solbach C, Karn T, Ataseven B, Sinn BV, Barinoff J, et al. Journal article Expression of nectin-4 in papillary renal cell carcinoma (2022) Zschabitz S, Mikuteit M, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Palaeogenomic analysis of black rat (Rattus rattus) reveals multiple European introductions associated with human economic history (2022) Yu H, Jamieson A, Hulme-Beaman A, Conroy CJ, Knight B, Speller C, Al-Jarah H, et al. Journal article Increased expression of OLFM4 and lysozyme during necrotizing enterocolitis in neonates: an observational research study (2022) Diez S, Renner M, Bahlinger V, Hartmann A, Besendörfer M, Müller H Journal article DMBT1 is upregulated in cystic fibrosis, affects ciliary motility, and is reduced by acetylcysteine (2022) Kiefer A, Plattner E, Ruppel R, Weiss C, Zhou-Suckow Z, Mall M, Renner M, Müller H Journal article Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST) (2022) Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, et al. Conference contribution Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial (2022) Roellig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Haenel M, et al. Conference contribution Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group (2022) Burchert A, Saussele S, Michel C, Metzelder SK, Hochhaus A, Gattermann N, Crysandt M, et al. Conference contribution Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis (2022) Unglaub JM, Schlenk RF, Hanoun M, Reinhardt HC, Middeke JM, Schaefer-Eckart K, Steffen B, et al. Conference contribution ICC++: Explainable Feature Learning for Art History using Image Compositions (2022) Madhu P, Marquart T, Kosti RV, Suckow D, Bell P, Maier A, Christlein V Journal article